Vericel to Present at Ladenburg Thalmann Healthcare Conference
September 21 2016 - 8:00AM
Vericel Corporation (Nasdaq:VCEL), a leading developer of
autologous cellular therapies for the treatment of severe diseases
and conditions, today announced that Nick Colangelo, president and
CEO, and Gerard Michel, chief financial officer and vice president
of corporate development, will present at the Ladenburg Thalmann
2016 Healthcare Conference at Sofitel Hotel in New York City, NY on
Tuesday, September 27, 2016, at 11:30am Eastern time.
The presentation will be webcast live and may be
accessed from the news and events section of the Vericel
website: http://wsw.com/webcast/ladenburg2/vcel.
About Vericel Corporation
Vericel develops, manufactures, and markets
autologous expanded cell therapies for the treatment of patients
with serious diseases and conditions. The company markets two
cell therapy products in the United States. Carticel®
(autologous cultured chondrocytes) is an autologous chondrocyte
implant for the treatment of cartilage defects in the knee in
patients who have had an inadequate response to a prior
arthroscopic or other surgical repair procedure. Epicel®
(cultured epidermal autografts) is a permanent skin replacement for
the treatment of patients with deep dermal or full thickness burns
greater than or equal to 30% of total body surface area.
Vericel is also developing two additional cell products.
MACI® is a third generation autologous chondrocyte implant intended
to treat cartilage defects in the knee. Ixmyelocel‑T is an
autologous multicellular therapy intended to treat advanced heart
failure due to ischemic dilated cardiomyopathy (DCM). For
more information, please visit the company's website at
www.vcel.com.
Epicel®, Carticel® and MACI® are registered
trademarks of Vericel Corporation. ©2016 Vericel
Corporation. All rights reserved.
CONTACT:
Chad Rubin
The Trout Group
crubin@troutgroup.com
(646) 378-2947
or
Lee Stern
The Trout Group
lstern@troutgroup.com
(646) 378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024